Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CUBI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Philip Watkins EVP, Head of Corp Devel & IR | CUBI Customers Bancorp, Inc | Sale | 5,500 | $86.17 | $473.9K Sale | Form 4 ↗ |
| Nov 2, 2026 | T. Lawrence Way Director | CUBI Customers Bancorp, Inc | Sale | 723 | $85.16 | $61.6K Sale | Form 4 ↗ |
| Oct 30, 2026 | T. Lawrence Way Director | CUBI Customers Bancorp, Inc | Sale | 48,796 | $83.88 | $4.1M Sale | Form 4 ↗ |
| Oct 29, 2026 | Jay S. Sidhu Exec. Chairman, Director | CUBI Customers Bancorp, Inc | Sale | 50,000 | $87.40 | $4.4M Sale | Form 4 ↗ |
| Aug 13, 2026 | Andrea R. Allon Director | CUBI Customers Bancorp, Inc | Sale | 10,000 | $82.81 | $828.1K Sale | Form 4 ↗ |
| Aug 3, 2026 | Jay S. Sidhu Chairman, Director | CUBI Customers Bancorp, Inc | Sale | 68,821 | $80.09 | $5.5M Sale | Form 4 ↗ |
| Jul 30, 2026 | Jay S. Sidhu Chairman, Director | CUBI Customers Bancorp, Inc | Sale | 835 | $79.00 | $66.0K Sale | Form 4 ↗ |
| Jul 29, 2026 | Jay S. Sidhu Chairman, Director | CUBI Customers Bancorp, Inc | Sale | 30,344 | $79.20 | $2.4M Sale | Form 4 ↗ |
| May 29, 2026 | Lyle Cunningham Chief Banking Officer | CUBI Customers Bancorp, Inc | Sale | 47,914 | $75.03 | $3.6M Sale | Form 4 ↗ |
| May 27, 2026 | Jay S. Sidhu Chairman, Director | CUBI Customers Bancorp, Inc | Sale | 60,315 | $76.23 | $4.6M Sale | Form 4 ↗ |
| May 12, 2026 | Samvir S. Sidhu CEO, Director | CUBI Customers Bancorp, Inc | Buy | 1,000 | $72.58 | $72.6K Buy | Form 4 ↗ |
| May 11, 2026 | Philip Watkins EVP, Head of Corp Development | CUBI Customers Bancorp, Inc | Sale | 3,000 | $75.67 | $227.0K Sale | Form 4 ↗ |
| Dec 9, 2025 | John Deano Velasquez Jessie Chief Accounting Officer | CUBI Customers Bancorp, Inc | Sale | 2,242 | $71.05 | $159.3K Sale | Form 4 ↗ |
| Dec 3, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 128,185 | $69.43 | $8.9M Sale | Form 4 ↗ |
| Nov 25, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 7,479 | $70.06 | $524.0K Sale | Form 4 ↗ |
| Nov 24, 2025 | Philip Watkins EVP, Head of Corp Development | CUBI Customers Bancorp, Inc | Sale | 2,900 | $65.04 | $188.6K Sale | Form 4 ↗ |
| Nov 12, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 2,522 | $68.39 | $172.5K Sale | Form 4 ↗ |
| Nov 11, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 24,784 | $68.05 | $1.7M Sale | Form 4 ↗ |
| Nov 10, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 13,595 | $68.69 | $933.8K Sale | Form 4 ↗ |
| Nov 7, 2025 | Bernard Bennett Banks Director | CUBI Customers Bancorp, Inc | Sale | 9,000 | $66.93 | $602.4K Sale | Form 4 ↗ |
| Nov 6, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 1,263 | $67.75 | $85.6K Sale | Form 4 ↗ |
| Nov 5, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 22,172 | $67.76 | $1.5M Sale | Form 4 ↗ |
| Feb 4, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 67,000 | $56.82 | $3.8M Sale | Form 4 ↗ |
| Jan 31, 2025 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 33,173 | $57.25 | $1.9M Sale | Form 4 ↗ |
| Jan 30, 2025 | Glenn Hedde Pres Mortgage WarehouseLending | CUBI Customers Bancorp, Inc | Sale | 15,815 | $58.25 | $921.2K Sale | Form 4 ↗ |
| Nov 20, 2024 | Robert Neil Mackay Director | CUBI Customers Bancorp, Inc | Sale | 4,000 | $53.78 | $215.1K Sale | Form 4 ↗ |
| Nov 11, 2024 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 86,578 | $56.54 | $4.9M Sale | Form 4 ↗ |
| Nov 8, 2024 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 12,562 | $53.01 | $665.9K Sale | Form 4 ↗ |
| Nov 7, 2024 | Jay S. Sidhu Chairman & CEO, Director | CUBI Customers Bancorp, Inc | Sale | 860 | $54.73 | $47.1K Sale | Form 4 ↗ |
| Nov 6, 2024 | Glenn Hedde Pres Mortgage WarehouseLending | CUBI Customers Bancorp, Inc | Sale | 5,002 | $53.68 | $268.5K Sale | Form 4 ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:01 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances